Cargando…

Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis

BACKGROUND: This meta-analysis on peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder (MDD) examined which compounds change following psychopharmacological treatment. METHODS: The Embase, PubMed and PsycINFO databases were systematic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Çakici, Nuray, Sutterland, Arjen L., Penninx, Brenda W. J. H., de Haan, Lieuwe, van Beveren, Nico J. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020491/ https://www.ncbi.nlm.nih.gov/pubmed/33653423 http://dx.doi.org/10.1017/S0033291721000155

Ejemplares similares

A Visual Metaphor Describing Neural Dynamics in Schizophrenia
por: van Beveren, Nico J. M., et al.
Publicado: (2008)

O5.1. CLOZAPINE AND LONG-TERM MORTALITY RISK IN PATIENTS WITH SCHIZOPHRENIA: PRELIMINARY RESULTS FROM A META-ANALYSIS
por: Vermeulen, Jentien, et al.
Publicado: (2018)

Predictive biomarkers for negative symptoms in schizophrenia
por: Cakici, N., et al.
Publicado: (2021)

Psychopharmacology of schizophrenia: The Future Looks Bleak
por: Andrade, Chittaranjan, et al.
Publicado: (2012)

Psychopharmacological treatment for schizophrenia: less is more
por: WANG, Chuanyue
Publicado: (2015)

Marked Reduction of AKT1 Expression and Deregulation of AKT1-Associated Pathways in Peripheral Blood Mononuclear Cells of Schizophrenia Patients
por: van Beveren, Nico J. M., et al.
Publicado: (2012)

Reduced Context Effects on Retrieval in First-Episode Schizophrenia
por: Talamini, Lucia M., et al.
Publicado: (2010)

Specificity of facial emotion recognition impairments in patients with multi-episode schizophrenia
por: Barkhof, Emile, et al.
Publicado: (2015)

CHRONIC SCHIZOPHRENIA—A PSYCHOPHARMACOLOGICAL APROACH1
por: Ban, Thomas A., et al.
Publicado: (1984)

Gender Differences in the Psychopharmacological Treatment of Forensic In-Patients With Schizophrenia
por: Mayer, Juliane, et al.
Publicado: (2022)

Psychopharmacology
Publicado: (1989)

Psychopharmacology
por: McInerney, Shane, et al.
Publicado: (2014)

Psychopharmacology
por: Pitt, Brice
Publicado: (1968)

Abnormalities of Electroencephalography Microstates in Drug-Naïve, First-Episode Schizophrenia
por: Sun, Qiaoling, et al.
Publicado: (2022)

Sustained specialized and family treatment in first-episode schizophrenia or related disorders: a 5-year randomized controlled trial
por: de Haan, Lieuwe, et al.
Publicado: (2023)

Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders
por: de Haan, Lieuwe, et al.
Publicado: (2023)

Alterations of Intrinsic Connectivity Networks in Antipsychotic-Naïve First-Episode Schizophrenia
por: Anhøj, Simon, et al.
Publicado: (2018)

Similarities and differences of functional connectivity in drug-naïve, first-episode adolescent and young adult with major depressive disorder and schizophrenia
por: Wei, Shengnan, et al.
Publicado: (2017)

Recent Advances in Psychopharmacology: From Bench to Bedside Novel Trends in Schizophrenia
por: Shah, Asim A., et al.
Publicado: (2023)

Psychopharmacological Agents
por: Tucker, Gary J.
Publicado: (1968)

Psychopharmacology of Clonidine
por: Krystal, John, et al.
Publicado: (1982)

The Psychopharmacology of Lithium
por: Krystal, John H.
Publicado: (1986)

The creation of psychopharmacology
por: Dyck, Erika
Publicado: (2003)

Competent Psychopharmacology
por: Gardner, David M
Publicado: (2014)

Ethno-psychopharmacology
por: Skuse, David
Publicado: (2007)

Plasma dopa decarboxylase activity in treatment-resistant recent-onset psychosis patients
por: van der Pluijm, Marieke, et al.
Publicado: (2019)

Psychopharmacology : basic mechanisms and applied interventions /
Publicado: (1992)

Psychopharmacology : a biochemical and behavioral approach /
por: Seiden, Lewis S.
Publicado: (1977)

Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naïve Patients with Schizophrenia
por: Yao, Jeffrey K., et al.
Publicado: (2010)

Impaired Binocular Depth Perception in First-Episode Drug-Naive Patients With Schizophrenia
por: Wang, Zhengchun, et al.
Publicado: (2018)

Depth‐dependent abnormal cortical myelination in first‐episode treatment‐naïve schizophrenia
por: Wei, Wei, et al.
Publicado: (2020)

The Role of Butyric Acid in Treatment Response in Drug-Naïve First Episode Schizophrenia
por: Li, Xue, et al.
Publicado: (2021)

Age-associated network controllability changes in first episode drug-naïve schizophrenia
por: Tang, Biqiu, et al.
Publicado: (2022)

Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia
por: Wei, Qianqian, et al.
Publicado: (2022)

The importance of blood count and oxidative stress in the drug-naïve first episode schizophrenia
por: Rog, J., et al.
Publicado: (2022)

Ameliorative patterns of grey matter in patients with first-episode and treatment-naïve schizophrenia
por: Li, Mingli, et al.
Publicado: (2023)

Child psychopharmacology: Is it more similar than different from adult psychopharmacology?
por: Sareen, Himanshu, et al.
Publicado: (2013)

A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project
por: Bioque, Miquel, et al.
Publicado: (2015)

Human psychopharmacology : measures and methods
Publicado: (1987)

EDITORIAL Brain Structural and Functional Effects of Psychopharmacological Treatment in the Major Psychoses
por: Vita, Antonio, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_epsbuj6t37himo1doks11hqe8k